Cetera Investment Advisers Bio Rad Laboratories, Inc. Transaction History

Cetera Investment Advisers

$44.2 Billion
Q3 2024

A detailed history of Cetera Investment Advisers transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 1,688 shares of BIO stock, worth $557,934. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,688

Previous 2,015 16.23%

Holding current value

$557,934

Previous $550,000 2.55%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$263.97 - $344.64 $86,318 - $112,697	-327 Reduced 16.23%	1,688 $564,000
Q2 2024 Aug 22, 2024	SELL	$268.26 - $339.48 $138,422 - $175,171	-516 Reduced 20.39%	2,015 $550,000
Q1 2024 May 24, 2024	BUY	$304.11 - $351.99 $558,650 - $646,605	1,837 Added 264.7%	2,531 $875,000
Q1 2024 May 14, 2024	SELL	$304.11 - $351.99 $245,416 - $284,055	-807 Reduced 53.76%	694 $240,000
Q4 2023 Feb 13, 2024	SELL	$269.37 - $365.04 $175,629 - $238,006	-652 Reduced 30.28%	1,501 $484,000
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $208,048 - $251,042	594 Added 38.1%	2,153 $771,000
Q2 2023 Aug 09, 2023	SELL	$359.49 - $486.4 $37,386 - $50,585	-104 Reduced 6.25%	1,559 $591,000
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $8,373 - $10,060	-20 Reduced 1.19%	1,663 $796,000
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $86,168 - $111,722	245 Added 17.04%	1,683 $707,000
Q3 2022 Nov 10, 2022	BUY	$412.59 - $563.26 $275,197 - $375,694	667 Added 86.51%	1,438 $1,000
Q2 2022 Aug 11, 2022	SELL	$463.67 - $597.16 $185,931 - $239,461	-401 Reduced 34.22%	771 $382,000
Q1 2022 May 13, 2022	SELL	$524.57 - $735.42 $110,159 - $154,438	-210 Reduced 15.2%	1,172 $660,000
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $232,499 - $260,655	328 Added 31.12%	1,382 $1.04 Million
Q3 2021 Nov 16, 2021	SELL	$657.71 - $825.77 $67,744 - $85,054	-103 Reduced 8.9%	1,054 $786,000
Q2 2021 Aug 13, 2021	BUY	$576.64 - $649.04 $164,342 - $184,976	285 Added 32.68%	1,157 $745,000
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $209,504 - $253,680	383 Added 78.32%	872 $498,000
Q4 2020 Feb 17, 2021	BUY	$510.68 - $643.45 $249,722 - $314,647	489 New	489 $285,000

Others Institutions Holding BIO

# of Institutions

456

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.14B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Bio Rad Laboratories, Inc. Transaction History